Shanghai Labway Clinical Laboratory Co Ltd (301060) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.081x

Based on the latest financial reports, Shanghai Labway Clinical Laboratory Co Ltd (301060) has a cash flow conversion efficiency ratio of 0.081x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥135.78 Million ≈ $19.87 Million USD) by net assets (CN¥1.67 Billion ≈ $244.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Labway Clinical Laboratory Co L liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Shanghai Labway Clinical Laboratory Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai Labway Clinical Laboratory Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Labway Clinical Laboratory Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Labway Clinical Laboratory Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shenzhen Kingsun Science Tech SHE:300235	-0.018x
SGC Energy Co Ltd KO:005090	-0.033x
Chengdu Lihang Technology Co.Ltd. SHG:603261	N/A
Mahindra Holidays & Resorts India Limited NSE:MHRIL	0.349x
Shandong Oriental Ocean Sci-Tech Co Ltd SHE:002086	-0.035x
Braskem SA Class A NYSE:BAK	0.260x
Anhui Wantong Technology Co Ltd SHE:002331	-0.065x
SNT Holdings Co Ltd KO:036530	-0.006x

Annual Cash Flow Conversion Efficiency for Shanghai Labway Clinical Laboratory Co Ltd (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Labway Clinical Laboratory Co Ltd from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai Labway Clinical Laboratory Co L stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥1.64 Billion ≈ $240.69 Million	CN¥268.85 Million ≈ $39.34 Million	0.163x	+37.55%
2024-12-31	CN¥1.82 Billion ≈ $266.37 Million	CN¥216.31 Million ≈ $31.65 Million	0.119x	-56.98%
2023-12-31	CN¥1.98 Billion ≈ $289.76 Million	CN¥546.99 Million ≈ $80.04 Million	0.276x	+645.91%
2022-12-31	CN¥2.27 Billion ≈ $332.58 Million	CN¥84.17 Million ≈ $12.32 Million	0.037x	-72.83%
2021-12-31	CN¥1.64 Billion ≈ $239.96 Million	CN¥223.51 Million ≈ $32.71 Million	0.136x	+1.28%
2020-12-31	CN¥1.25 Billion ≈ $182.53 Million	CN¥167.87 Million ≈ $24.57 Million	0.135x	+131.24%
2019-12-31	CN¥1.21 Billion ≈ $177.52 Million	CN¥70.60 Million ≈ $10.33 Million	0.058x	-62.80%
2018-12-31	CN¥1.18 Billion ≈ $172.83 Million	CN¥184.79 Million ≈ $27.04 Million	0.156x	+280.90%
2017-12-31	CN¥1.10 Billion ≈ $161.60 Million	CN¥-95.52 Million ≈ $-13.98 Million	-0.086x	-295.93%
2016-12-31	CN¥614.70 Million ≈ $89.95 Million	CN¥27.14 Million ≈ $3.97 Million	0.044x	-83.09%
2015-12-31	CN¥305.25 Million ≈ $44.67 Million	CN¥79.70 Million ≈ $11.66 Million	0.261x	+163.44%
2014-12-31	CN¥201.13 Million ≈ $29.43 Million	CN¥-82.77 Million ≈ $-12.11 Million	-0.412x	-3402.03%
2013-12-31	CN¥130.79 Million ≈ $19.14 Million	CN¥1.63 Million ≈ $238.52K	0.012x	--

About Shanghai Labway Clinical Laboratory Co Ltd

SHE:301060 China Diagnostics & Research

Market Cap

$507.55 Million

CN¥3.47 Billion CNY

Market Cap Rank

#12312 Global

#3602 in China

Share Price

CN¥8.66

Change (1 day)

+2.12%

52-Week Range

CN¥8.27 - CN¥13.68

All Time High

CN¥52.42